These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20832308)

  • 41. Motor neuron pathology and behavioral alterations at late stages in a SMA mouse model.
    Fulceri F; Bartalucci A; Paparelli S; Pasquali L; Biagioni F; Ferrucci M; Ruffoli R; Fornai F
    Brain Res; 2012 Mar; 1442():66-75. PubMed ID: 22306031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice.
    Tsai LK; Tsai MS; Ting CH; Li H
    J Mol Med (Berl); 2008 Nov; 86(11):1243-54. PubMed ID: 18649067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AAV9-DOK7 gene therapy reduces disease severity in Smn
    Kaifer KA; Villalón E; Smith CE; Simon ME; Marquez J; Hopkins AE; Morcos TI; Lorson CL
    Biochem Biophys Res Commun; 2020 Sep; 530(1):107-114. PubMed ID: 32828271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate.
    Garbes L; Riessland M; Hölker I; Heller R; Hauke J; Tränkle C; Coras R; Blümcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2009 Oct; 18(19):3645-58. PubMed ID: 19584083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.
    Baughan T; Shababi M; Coady TH; Dickson AM; Tullis GE; Lorson CL
    Mol Ther; 2006 Jul; 14(1):54-62. PubMed ID: 16580882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcriptome profiling of spinal muscular atrophy motor neurons derived from mouse embryonic stem cells.
    Maeda M; Harris AW; Kingham BF; Lumpkin CJ; Opdenaker LM; McCahan SM; Wang W; Butchbach ME
    PLoS One; 2014; 9(9):e106818. PubMed ID: 25191843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy.
    Shanmugarajan S; Tsuruga E; Swoboda KJ; Maria BL; Ries WL; Reddy SV
    J Pathol; 2009 Sep; 219(1):52-60. PubMed ID: 19434631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy.
    Poort JE; Rheuben MB; Breedlove SM; Jordan CL
    Hum Mol Genet; 2016 Sep; 25(17):3768-3783. PubMed ID: 27493028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of the DcpS inhibitor D156844 on the protective action of follistatin in mice with spinal muscular atrophy.
    Harris AW; Butchbach ME
    Neuromuscul Disord; 2015 Sep; 25(9):699-705. PubMed ID: 26055638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy.
    Naryshkin NA; Weetall M; Dakka A; Narasimhan J; Zhao X; Feng Z; Ling KK; Karp GM; Qi H; Woll MG; Chen G; Zhang N; Gabbeta V; Vazirani P; Bhattacharyya A; Furia B; Risher N; Sheedy J; Kong R; Ma J; Turpoff A; Lee CS; Zhang X; Moon YC; Trifillis P; Welch EM; Colacino JM; Babiak J; Almstead NG; Peltz SW; Eng LA; Chen KS; Mull JL; Lynes MS; Rubin LL; Fontoura P; Santarelli L; Haehnke D; McCarthy KD; Schmucki R; Ebeling M; Sivaramakrishnan M; Ko CP; Paushkin SV; Ratni H; Gerlach I; Ghosh A; Metzger F
    Science; 2014 Aug; 345(6197):688-93. PubMed ID: 25104390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rescue of gene-expression changes in an induced mouse model of spinal muscular atrophy by an antisense oligonucleotide that promotes inclusion of SMN2 exon 7.
    Staropoli JF; Li H; Chun SJ; Allaire N; Cullen P; Thai A; Fleet CM; Hua Y; Bennett CF; Krainer AR; Kerr D; McCampbell A; Rigo F; Carulli JP
    Genomics; 2015 Apr; 105(4):220-8. PubMed ID: 25645699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac defects contribute to the pathology of spinal muscular atrophy models.
    Shababi M; Habibi J; Yang HT; Vale SM; Sewell WA; Lorson CL
    Hum Mol Genet; 2010 Oct; 19(20):4059-71. PubMed ID: 20696672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.
    Brichta L; Hofmann Y; Hahnen E; Siebzehnrubl FA; Raschke H; Blumcke I; Eyupoglu IY; Wirth B
    Hum Mol Genet; 2003 Oct; 12(19):2481-9. PubMed ID: 12915451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrastructural characterization of peripheral denervation in a mouse model of Type III spinal muscular atrophy.
    Fulceri F; Biagioni F; Limanaqi F; Busceti CL; Ryskalin L; Lenzi P; Fornai F
    J Neural Transm (Vienna); 2021 Jun; 128(6):771-791. PubMed ID: 33999256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The ultrastructure of peripheral nerve, motor end-plate and skeletal muscle in patients suffering from spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Diers A; Kaczinski M; Grohmann K; Hübner C; Stoltenburg-Didinger G
    Acta Neuropathol; 2005 Sep; 110(3):289-97. PubMed ID: 16025284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.
    Passini MA; Bu J; Roskelley EM; Richards AM; Sardi SP; O'Riordan CR; Klinger KW; Shihabuddin LS; Cheng SH
    J Clin Invest; 2010 Apr; 120(4):1253-64. PubMed ID: 20234094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Motor neuron mitochondrial dysfunction in spinal muscular atrophy.
    Miller N; Shi H; Zelikovich AS; Ma YC
    Hum Mol Genet; 2016 Aug; 25(16):3395-3406. PubMed ID: 27488123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy.
    Deguise MO; Boyer JG; McFall ER; Yazdani A; De Repentigny Y; Kothary R
    Sci Rep; 2016 Jun; 6():28846. PubMed ID: 27349908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy.
    Tarabal O; Caraballo-Miralles V; Cardona-Rossinyol A; Correa FJ; Olmos G; Lladó J; Esquerda JE; Calderó J
    J Neuropathol Exp Neurol; 2014 Jun; 73(6):519-35. PubMed ID: 24806302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.